Eaton Vance Worldwide Health Sciences Fund Class R ERHSX

Medalist Rating as of | See Eaton Vance Investment Hub
  • NAV / 1-Day Return 14.56  /  −1.29 %
  • Total Assets 790.7M
  • Adj. Expense Ratio
    1.430%
  • Expense Ratio 1.420%
  • Distribution Fee Level Average
  • Share Class Type Retirement, Medium
  • Category Health
  • Investment Style Large Value
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.21%
  • Turnover 30%

USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 12:10 AM GMT+0

Morningstar’s Analysis ERHSX

Will ERHSX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

A decent global healthcare vehicle for the long haul.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Eaton Vance Worldwide Health Sciences is a solid source of global healthcare exposure, rather than a superior one.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ERHSX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 58.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

12.51 95M
Healthcare

AbbVie Inc

6.47 49M
Healthcare

Johnson & Johnson

6.47 49M
Healthcare

AstraZeneca PLC

6.26 47M
Healthcare

UnitedHealth Group Inc

5.50 42M
Healthcare

Roche Holding AG

5.46 41M

Merck & Co Inc

5.09 38M
Healthcare

Bristol-Myers Squibb Co

4.27 32M
Healthcare

Vertex Pharmaceuticals Inc

3.39 26M
Healthcare

Gilead Sciences Inc

3.35 25M
Healthcare

Sponsor Center